Home Capital Broker's Calls

Analysts make mixed recommendations for Frencken as rising costs remain a key consideration

Bryan Wu
Bryan Wu8/16/2022 11:47 AM GMT+08  • 4 min read
Analysts make mixed recommendations for Frencken as rising costs remain a key consideration
Analysts are mixed on Frencken Group’s outlook following the release of its 1HFY2022 results
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts are mixed on Frencken Group’s (Frencken) outlook following the release of its 1HFY2022 results.

CGS-CIMB Research’s William Tng and UOB Kay Hian’s John Cheong maintained their “add” and “buy” calls respectively, with Tng raising his target price (TP) slightly to $1.75 from $1.72 and Cheong lowering his to $1.60 from $1.63.

Meanwhile, DBS Research maintained its “hold” call for Frencken with an unchanged TP of $1.36 while RHB Group Research’s Jarick Seet downgraded his call to “neutral” from “buy” with a TP of $1.24.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.